Adalimumab Richmond (adalimumab biosimilar)
/ Laboratorios Richmond
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 05, 2024
A Clinical Study With Adalimumab Biosimilar
(clinicaltrials.gov)
- P1 | N=150 | Completed | Sponsor: Laboratorios Richmond S.A.C.I.F.
New P1 trial
1 to 1
Of
1
Go to page
1